With the analysis among 929 patents, we discovered top 434 key players by total patent application. Pharma Mar SA, Millennium Pharmaceuticals, Inc., Zibo Quark Medical Technology Co., Ltd. are dominant in this area. They take 4.09% of the total patent filing.
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 13
Zibo Quark Medical Technology Co., Ltd.
Shandong Sheng, China
Patent: 12
New York, United States
Patent: 11
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 11
Alkermes Pharma Ireland Ltd.
Laboratory Corp. of America Holdings
North Carolina, United States
Patent: 10
Gan & Lee Pharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 10
New Jersey, United States
Patent: 10
Hebei Yiling Pharmaceutical Research Institute Co., Ltd.
Hebei Sheng, China
Patent: 10
With the analysis among 32 patents, we discovered top 13 start-ups by total patent application. Proteus Digital Health, Inc., Intarcia Therapeutics, Inc., Invitrox, Inc. are active in this area.
Proteus Digital Health, Inc.
California, United States
Patent: 8
Intarcia Therapeutics, Inc.
California, United States
Patent: 7
North Carolina, United States
Patent: 3
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 2
Institut National de la Santé et de la Recherche Médicale
Jiangsu Quanxin Biomedical Co Ltd
Jiangsu Sheng, China
Patent: 2
Massachusetts, United States
Patent: 2
California, United States
Patent: 1
Beijing Huabin Licheng Technology Co. Ltd.
Beijing Shi, China
Patent: 1
Genesky Technology (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 1
With the analysis among related 226 patents applied in the last 5 years. We discover 145 most active companies in this area. The fast-growing Merck Patent GmbH, Intarcia Therapeutics, Inc., G1 Therapeutics, Inc. take 9.29% of patent filing during this period.
Intarcia Therapeutics, Inc.
California, United States
Patent: 7
North Carolina, United States
Patent: 6
California, United States
Patent: 6
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 5
Gan & Lee Pharmaceuticals Co., Ltd.
Beijing Shi, China
Patent: 4
Puri Benchmark Biomedicine (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 4
Nanjing Puenrui Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
With the analysis among related 226 patents in last 5 years, we discover 131 new entrants. Merck Patent GmbH, Intarcia Therapeutics, Inc., G1 Therapeutics, Inc. are the most active new entrants in this area.
Intarcia Therapeutics, Inc.
California, United States
Patent: 7
North Carolina, United States
Patent: 6
California, United States
Patent: 6
F. Hoffmann-La Roche Ltd.
Basel-Stadt, Switzerland
Patent: 5
Puri Benchmark Biomedicine (Suzhou) Co., Ltd.
Jiangsu Sheng, China
Patent: 4
Nanjing Puenrui Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Precision Scientific (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 3
With the analysis among 213 patents, we discovered top 75 universities and scientific research institutions by total patent application. Université Laval, President & Fellows of Harvard College, Duke University are dominant in this area. They take 18.31% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 6
North Carolina, United States
Patent: 4
The University of Chicago
Illinois, United States
Patent: 4
Case Western Reserve University
Ohio, United States
Patent: 4
Sichuan Sheng, China
Patent: 3
Zhejiang Sheng, China
Patent: 3
DUNDEE, United Kingdom
Patent: 3
Alabama, United States
Patent: 3
Guangxi University of Chinese Medicine
Guangxi Zhuangzu Zizhiqu, China
Patent: 3